EUVIMEDEUVIMED entdecken
Crossref

Post‐Tonsillectomy Bleeding and Analgesic Use Before and After the FDA Boxed Warning Against Codeine

Chloe Cottone iD, Arunima Vijay, Anjalika Chalamgari, Michele M Carr iD

The Laryngoscope · 2024

DOI: 10.1002/lary.31542 ↗

Kurz gefasst

Fachartikel in der Zeitschrift The Laryngoscope, 2024. Verfasst von Chloe Cottone und 3 weiteren Autor:innen. Beteiligte Einrichtung: Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, New York, U.S.A. Hauptthemen laut MEDLINE: Tonsillectomy, Codeine, United States Food and Drug Administration, Postoperative Hemorrhage. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 41 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to investigate the trends in post‐tonsillectomy analgesic utility and incidence of post‐tonsillectomy hemorrhage before and after the 2013 FDA Boxed Warning against codeine use after pediatric tonsillectomy.

Methods

A retrospective study was conducted using TriNetX. A search for patients up to 18 years from 2008 to 2022 within the US Collaborative Network identified 15,648,542 subjects. CPT and ICD‐10 codes were used to identify children who experienced post‐tonsillectomy hemorrhage within 14 days of a tonsillectomy. Analgesics given within 14 days of tonsillectomy were tabulated annually from 2008 to 2022, including codeine, ibuprofen, acetaminophen, oxycodone, ketorolac, and hydrocodone. Bleeding percentage and analgesic utility were grouped into events before and after 2013.

Results

Mean age at tonsillectomy was 5.6 years (SD = 3.0). Before 2013, the median percentage of children who experienced postoperative bleeding was 1.8% with 0.73% returning to the OR for bleeding control. After 2013, the median percentage of children who experienced postoperative bleeding was 2.4% ( p = 0.029), and 0.99% returned to the OR ( p = 0.008). Use of post‐tonsillectomy codeine fell from 10.4% to 0.5% ( p = 0.003) whereas ibuprofen rose from 2.0% to 63.9% ( p =

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TonsillectomyCodeineUnited States Food and Drug AdministrationPostoperative HemorrhagePostoperative PainHumansUnited StatesRetrospective StudiesChild, PreschoolChildMaleFemaleAnalgesics, OpioidDrug LabelingAdolescentIbuprofenIncidenceAcetaminophen

Stichwörter der Autor:innen

FDA Boxed Warningcodeineibuprofenpost‐operative analgesicspost‐tonsillectomy bleedingpost‐tonsillectomy hemorrhagetonsillectomy

Substanzen

CodeineAnalgesics, OpioidIbuprofenAcetaminophen

Autor:innen und Institutionen

  • Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, New York, U.S.A.
  • University of Florida College of Medicine, Gainesville, Florida, U.S.A.
  • Department of Otolaryngology, Jacobs School of Medicine and Biomedical Sciences, The State University of New York at Buffalo, Buffalo, New York, U.S.A.

ORCID-Profile: Chloe Cottone, Michele M Carr

Zitieren

APA

Cottone, C., Vijay, A., Chalamgari, A., & Carr, M. M. (2024). Post‐Tonsillectomy Bleeding and Analgesic Use Before and After the FDA Boxed Warning Against Codeine. The Laryngoscope. https://doi.org/10.1002/lary.31542

Vancouver

Cottone C, Vijay A, Chalamgari A, Carr MM. Post‐Tonsillectomy Bleeding and Analgesic Use Before and After the FDA Boxed Warning Against Codeine. The Laryngoscope. 2024. doi:10.1002/lary.31542

BibTeX
@article{Cottone2024,
  author = {Cottone, Chloe and Vijay, Arunima and Chalamgari, Anjalika and Carr, Michele M},
  title = {Post‐Tonsillectomy Bleeding and Analgesic Use Before and After the FDA Boxed Warning Against Codeine},
  journal = {The Laryngoscope},
  year = {2024},
  doi = {10.1002/lary.31542}
}
Kostenlos starten →